aTyr Pharma News - LIFE

Company Name	Stock Ticker Symbol	Market	Type
aTyr Pharma Inc	LIFE	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	1.60	07:00:08

Open Price	Low Price	High Price	Close Price	Prev Close
				1.60

more quote information »

Recent News

Date	Time	Source	Heading
4/01/2024	08:00	GLOBE	aTyr Pharma to Participate in April Investor Conferences
3/14/2024	16:00	GLOBE	aTyr Pharma Announces Fourth Quarter and Full Year 2023..
2/28/2024	08:00	GLOBE	aTyr Pharma to Webcast Conference Call Reporting Fourth..
2/21/2024	08:00	GLOBE	aTyr Pharma Announces Expanded Access Program (EAP) for..
2/06/2024	20:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/06/2024	20:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/29/2024	08:00	GLOBE	aTyr Pharma to Present Posters Highlighting Importance of..
1/18/2024	08:00	GLOBE	aTyr Pharma Announces Howard University President Emeritus..
1/09/2024	19:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/09/2024	19:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/02/2024	12:21	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/12/2023	18:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/21/2023	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
11/13/2023	16:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/13/2023	08:00	GLOBE	aTyr Pharma Presents Poster Demonstrating Preclinical..
11/09/2023	17:01	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/09/2023	16:42	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/09/2023	16:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	16:06	EDGAR2	Form 8-K - Current report
11/09/2023	16:00	GLOBE	aTyr Pharma Announces Third Quarter 2023 Results and..
11/01/2023	08:00	GLOBE	aTyr Pharma to Present at November Investor Conferences
10/31/2023	08:00	GLOBE	aTyr Pharma Announces Dosing of First Patient in Phase 2..
9/26/2023	09:01	EDGAR2	Form 8-K - Current report
9/11/2023	08:04	EDGAR2	Form 8-K - Current report
9/11/2023	08:00	GLOBE	aTyr Pharma Presents Efzofitimod Data Demonstrating..
8/24/2023	08:00	GLOBE	aTyr Pharma to Present at the H.C. Wainwright 25th Annual..
8/10/2023	16:07	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/09/2023	16:14	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/2023	16:10	EDGAR2	Form 8-K - Current report
8/09/2023	16:00	GLOBE	aTyr Pharma Announces Second Quarter 2023 Results and..
8/01/2023	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/22/2023	08:00	GLOBE	European Commission Grants Orphan Drug Designation for aTyr..
6/20/2023	08:00	GLOBE	aTyr Pharma to Present on Lead Therapeutic Candidate..
6/09/2023	16:00	GLOBE	aTyr Pharma Announces Inducement Grants Under Nasdaq Listing..
6/06/2023	08:00	GLOBE	aTyr Pharma to Highlight Advancements in tRNA Synthetase..
5/25/2023	08:00	GLOBE	aTyr Pharma to Present at the 2023 Jefferies Healthcare..
5/22/2023	08:00	GLOBE	aTyr Pharma Presents New Data on Efzofitimod Mechanism of..
5/11/2023	16:00	GLOBE	aTyr Pharma to Present at the 2023 RBC Capital Markets..
5/09/2023	16:00	GLOBE	aTyr Pharma Announces First Quarter 2023 Results and..